Ross Levine MD

Two, the scientists most vulnerable right now are trainees and early career faculty. We need to prioritize their support bowever possible (public, foundation, institution) as they are the future and their ideas have the greatest potential to positively impact human health. 2/2

Two important points. One, the NIH review system is far from perfect, but the work of PIs who submit grants, the reviewers who thoughtfully assess them, and the low paylines means that the funded research is incredibly high quality and lots of great grants do not get funded. 1/

Running off the jet lag in Kona..

Lake waramug polar bear run!!

I believe that most of our society values science and scientists. We need to continue to communicate our findings and value to the public and advocate for increased research funding, especially for young investigators->they are the future.

@mskcancercenter.bsky.social cycle for survival! Time to ride and raise money for rare cancers

My challenge with blind review (which I understand has its merits) is that if we want to make the person/team a major factor how do you do this blindly? One model I have seen work is a blind review of LOIs with specific aims, and then unblinding the accepted LOIs when the full grant is reviewed.

Going post new things here and not on X. Will be focused on science/career development and drug development, with the occasional sports (Mets, Knicks, hockey) tweet..

Grants should focus more on the person/people doing the science>>the specific experimental minutae. Flexibility to follow the path the data illuminates>>>milestones and deliverables.

The best part of science for me is when someone in the lab or a former lab member has awesome new data and rushes to share it. everything else pales in comparison.

Knicks Lakers with Ariela! MSG for the win!

In chaotic times, it is important to emphasize how much i appreciate my fellow scientists and the science they do. Inspired countless times each day by my colleagues in the field.

First bluesky post! Here for the science and my colleagues in the field. @mskcancercenter.bsky.social